Q4 2024 Earnings Call Transcript March 27, 2025 Plus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.67 EPS, expectations were $-0.51. Operator: Good afternoon, ladies and ...

Welcome to Plus Therapeutics fourth quarter and full-year 2024 results conference call. Before we begin, we want to advise you that over the course of the call, including any question-and-answer ...